Both a strong TLR4 expression and the lack of TLR4 expression emerged as markers of aggressive disease, and those patients with metastasized disease had fewer CD45+ lymphocytes around the tumor compared to patients without metastases [36]. Here, PTPRC is linked to neoplasm.